Ladrx Corporation (LADX) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ladrx Corporation  (LADX)


Ladrx's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ladrx's ROI in the first quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Ladrx Corporation's return on investment (ROI) in its first quarter of 2025

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM - - - -72.48 % -15.7 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -2 -1 -2 -1 0
Return On Investment (TTM) - - - - 207.75 %
LADX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - -84.87 % 84.24 %
Seq. Net Income Change TTM - - - - 314.96 %
Net Income (TTM) in Millions -2 -2 -3 -3 2

LADX Company Profile >> Back to LADX Roi Comparisons >> See Annual LADX Return On Investment



Return On Investment LADX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Ladrx's I. Quarter Investments $ -2 Millions LADX's Balance sheet
Ladrx's I. Quarter Income $ -1 Millions Quarterly LADX's Income Statement
LADX's Income by Division See LADX's Income by Division


LADX Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions -1 0 0 5 9
Y / Y Investment Growth - 81.17 % -98.81 % -46.23 % -38.93 %
Net Income in Millions -2 0 -4 -13 -7
Y / Y Net Income Growth - - - - -
Annual Return On Investment - 372.91 % -7086.94 % -263.91 % -72.16 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LADX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LADX's Competitors
Subscribers only: Roi for Ladrx's Suppliers
Subscribers only: Return On Investment for LADX's Customers

Other Ratios
LADX's Roa LADX's Inventory Turnover Ratio LADX's Growth Rates LADX's Dividend Statistics
LADX's Profitability Ratios LADX's Asset Turnover Ratio LADX's Dividend Growth
LADX's Roe LADX's Valuation Ratios LADX's Financial Strength Ratios LADX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI
Capforce Inc   322.66 %
Pavmed Inc   314.73 %
Interpace Biosciences Inc   213.95 %
Cytomx Therapeutics Inc   139.64 %
Camp4 Therapeutics Corporation  136.24 %
Alumis inc   113.83 %
Stablecoin Development Corporation  110.75 %
Earth Science Tech Inc   100.58 %
Oak Woods Acquisition Corp  93.88 %
Avalo Therapeutics Inc   88.86 %
Tao Synergies Inc   78.95 %
Synlogic Inc   73.65 %
Novavax inc   71.31 %
Medinotec Inc   60.77 %
Exelixis Inc   59.41 %
Gridai Technologies Corp  58.38 %
Longduoduo Co Ltd  56.87 %
Adma Biologics Inc   53.77 %
Bluebird Bio Inc   52.44 %
Seres Therapeutics Inc   52.22 %
Pharmacyte Biotech Inc   48.77 %
Agios Pharmaceuticals Inc   48.46 %
Dariohealth Corp   44.97 %
Sbc Medical Group Holdings Incorporated  41.74 %
Champions Oncology Inc   41.16 %
Ptc Therapeutics inc   40.79 %
Rigel Pharmaceuticals Inc  39.96 %
Mettler toledo International Inc   39.75 %
Idexx Laboratories Inc  39.40 %
Edwards Lifesciences Corporation  38.53 %

Date modified: 2026-09-08T15:11:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.